Trial Profile
A study evaluating the evolution of residual viremia in HIV patients treated by boosted Atazanavir (ATV) and switched to unboosted ATV
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Mar 2016
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary) ; Emtricitabine/tenofovir disoproxil fumarate; Lamivudine/abacavir; Ritonavir
- Indications HIV infections
- Focus Therapeutic Use
- 02 Mar 2016 New trial record